Terms: = Liver cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Diagnosis
9821 results:
1. Expression of Fascin-1 and its diagnostic value in liver cancer.
Lu SP; Jiang LJ; Wang Y; Shao JK; Du ZQ; Huang BF; Wang CQ
Sci Rep; 2024 May; 14(1):10049. PubMed ID: 38698008
[TBL] [Abstract] [Full Text] [Related]
2. WNT5B drives osteosarcoma stemness, chemoresistance and metastasis.
Perkins RS; Murray G; Suthon S; Davis L; Perkins NB; Fletcher L; Bozzi A; Schreiber SL; Lin J; Laxton S; Pillai RR; Wright AJ; Miranda-Carboni GA; Krum SA
Clin Transl Med; 2024 May; 14(5):e1670. PubMed ID: 38689429
[TBL] [Abstract] [Full Text] [Related]
3. Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients.
Daher D; Seif El Dahan K; Rich NE; Tayob N; Merrill V; Huang DQ; Yang JD; Kulkarni AV; Kanwal F; Marrero J; Parikh N; Singal AG
JAMA Netw Open; 2024 Apr; 7(4):e248755. PubMed ID: 38683607
[TBL] [Abstract] [Full Text] [Related]
4. An assessment of risk factors for recurrence and survival for patients undergoing liver resection for intrahepatic cholangiocarcinoma.
Öztürk NB; Jamil LH
Eur J Gastroenterol Hepatol; 2024 Jun; 36(6):766-774. PubMed ID: 38683193
[TBL] [Abstract] [Full Text] [Related]
5. Epstein-Barr virus-associated post-transplant lymphoproliferative disorders in pediatric transplantation: A prospective multicenter study in the United States.
Tajima T; Martinez OM; Bernstein D; Boyd SD; Gratzinger D; Lum G; Sasaki K; Tan B; Twist CJ; Weinberg K; Armstrong B; Desai DM; Mazariegos GV; Chin C; Fishbein TM; Tekin A; Venick RS; Krams SM; Esquivel CO
Pediatr Transplant; 2024 Jun; 28(4):e14763. PubMed ID: 38682750
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Utility of Cytokeratins for Accurate diagnosis of Hepatocellular Carcinoma Among Hepatitis C Virus High-Risk Patients.
Al Haddad M; El-Mezayen HA; El-Kassas M; Metwally F; El-Sharkawy A
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1325-1332. PubMed ID: 38679993
[TBL] [Abstract] [Full Text] [Related]
7. Burden, Outcome, and Comorbidities of Extrahepatic Manifestations in Hepatitis B Virus Infections.
Songtanin B; Chaisrimaneepan N; Mendóza R; Nugent K
Viruses; 2024 Apr; 16(4):. PubMed ID: 38675959
[TBL] [Abstract] [Full Text] [Related]
8. Retrospective analysis of the incidence of appendiceal neoplasm and malignancy in patients treated for suspected acute appendicitis.
Dohner E; Kierdorf FJ; Langer R; Zuber M; Fahrner R
BMC Surg; 2024 Apr; 24(1):121. PubMed ID: 38658891
[TBL] [Abstract] [Full Text] [Related]
9. Identification and validation of a novel predictive signature based on hepatocyte-specific genes in hepatocellular carcinoma by integrated analysis of single-cell and bulk RNA sequencing.
He Y; Qi W; Xie X; Jiang H
BMC Med Genomics; 2024 Apr; 17(1):103. PubMed ID: 38654290
[TBL] [Abstract] [Full Text] [Related]
10. [A Case of Conversion Surgery for Unresectable Advanced Gastric cancer of Which Metastatic Site Was Disappear by Chemotherapy but the Primary Site Was Enlarged after Five Years].
Nomura A; Akamaru Y; Nishida K; Mori S; Yasuyama A; Nomura M; Yoshikawa Y; Tamai K; Takiuchi D; Hamakawa T; Tei M; Tsujie M
Gan To Kagaku Ryoho; 2024 Apr; 51(4):473-475. PubMed ID: 38644326
[TBL] [Abstract] [Full Text] [Related]
11. Increased prevalence but decreased survival of nonviral hepatocellular carcinoma compared to viral hepatocellular carcinoma in recent ten years.
Chen TC; Hsiao SW; Chen YY; Yen HH; Su WW; Hsu YC; Huang SP; Su PY
Sci Rep; 2024 Apr; 14(1):9068. PubMed ID: 38643245
[TBL] [Abstract] [Full Text] [Related]
12. Impact of influenza related hospitalization in Spain: characteristics and risk factor of mortality during five influenza seasons (2016 to 2021).
Ramos-Rincón JM; Pinargote-Celorio H; González-de-la-Aleja P; Sánchez-Payá J; Reus S; Rodríguez-Díaz JC; Merino E
Front Public Health; 2024; 12():1360372. PubMed ID: 38628848
[TBL] [Abstract] [Full Text] [Related]
13. Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review.
Sarofim M; Wijayawardana R; Ahmadi N; Morris DL
World J Surg Oncol; 2024 Apr; 22(1):99. PubMed ID: 38627808
[TBL] [Abstract] [Full Text] [Related]
14. Identification of an immune-related gene signature for predicting prognosis and immunotherapy efficacy in liver cancer
Li JT; Zhang HM; Wang W; Wei DQ
World J Gastroenterol; 2024 Mar; 30(11):1609-1620. PubMed ID: 38617448
[TBL] [Abstract] [Full Text] [Related]
15. Direct gastric invasion from the liver metastasis of colorectal origin: A case report.
Nam JY; Lee JW; Kim JH; Jung M; Park MI; Moon W; Kim SE; Jung K; Park SJ
Medicine (Baltimore); 2024 Apr; 103(15):e37732. PubMed ID: 38608071
[TBL] [Abstract] [Full Text] [Related]
16. Survival outcome following surgical versus non-surgical treatment of colorectal lung metastasis-a retrospective cohort study.
Denz A; Hahn V; Weber K; Weber GF; Grützmann R; Krautz C; Brunner M
Langenbecks Arch Surg; 2024 Apr; 409(1):121. PubMed ID: 38605271
[TBL] [Abstract] [Full Text] [Related]
17. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
18. Metastasis patterns and prognosis in young gastric cancer patients: A propensity score‑matched SEER database analysis.
Zhang H; Cheng X; Guo W; Zheng C; Zhang Y; Jing X; Qiao H
PLoS One; 2024; 19(4):e0301834. PubMed ID: 38593111
[TBL] [Abstract] [Full Text] [Related]
19. Challenges and technical aspects in the management of muscle invasive bladder cancer as retrograde radical cystectomy with ileal conduit.
Nusrat NB; Rehman AU; Zafar N; Muhammad S; Bajwa SI; Imtiaz S
J Pak Med Assoc; 2024 Mar; 74(3):513-518. PubMed ID: 38591289
[TBL] [Abstract] [Full Text] [Related]
20. A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY Tract cancers (BTC) at high risk for recurrence: PURITY study.
Niger M; Nichetti F; Fornaro L; Pircher C; Morano F; Palermo F; Rimassa L; Pressiani T; Berardi R; Gardini AC; Sperti E; Salvatore L; Melisi D; Bergamo F; Siena S; Mosconi S; Longarini R; Arcangeli G; Corallo S; Delliponti L; Tamberi S; Fea E; Brandi G; Rapposelli IG; Salati M; Baili P; Miceli R; Ljevar S; Cavallo I; Sottotetti E; Martinetti A; Busset MDD; Sposito C; Di Bartolomeo M; Pietrantonio F; de Braud F; Mazzaferro V
BMC Cancer; 2024 Apr; 24(1):436. PubMed ID: 38589856
[TBL] [Abstract] [Full Text] [Related]
[Next]